Patents by Inventor Angel Padilla
Angel Padilla has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 10736841Abstract: Novel compositions including bepotastine besilate and a corticosteroid are provided, compositions including at least about 0.008% w/v benzalkonium chloride, and compositions including hydroxypropylmethyl cellulose E15 LV.Type: GrantFiled: May 2, 2012Date of Patent: August 11, 2020Assignee: BAUSCH & LOMB INCORPORATEDInventors: Angel Padilla, George Baklayan
-
Publication number: 20180353451Abstract: Formulations and methods that provided enhanced bromfenac penetration into ocular tissue when topically administered, compared to the currently available BROMDAY™ formulation and method when topically administered. The formulations and methods did so while retaining the patient convenience of a once-daily administration and advantageously lowered the bromfenac concentration dosed to the patient.Type: ApplicationFiled: August 21, 2018Publication date: December 13, 2018Inventors: Angel Padilla, George Baklayan
-
Patent number: 10085958Abstract: Formulations and methods that provided enhanced bromfenac penetration into ocular tissue when topically administered, compared to the currently available BROMDAY™ formulation and method when topically administered. The formulations and methods did so while retaining the patient convenience of a once-daily administration and advantageously lowered the bromfenac concentration dosed to the patient.Type: GrantFiled: November 4, 2016Date of Patent: October 2, 2018Assignee: BAUSCH & LOMB PHARMA HOLDINGS CORP.Inventors: Angel Padilla, George Baklayan
-
Publication number: 20180250313Abstract: The present disclosure is directed to compositions, formulations and methods of use thereof in the treatment and prevention of ocular conditions including cataract and presbyopia.Type: ApplicationFiled: September 8, 2016Publication date: September 6, 2018Inventors: Leah MAKLEY, Angel PADILLA, David BAKER, Gary COOK, Harun TAKRURI, Jery CAGLE, Emmett CUMMINGHAM
-
Publication number: 20170049735Abstract: Formulations and methods that provided enhanced bromfenac penetration into ocular tissue when topically administered, compared to the currently available BROMDAY™ formulation and method when topically administered. The formulations and methods did so while retaining the patient convenience of a once-daily administration and advantageously lowered the bromfenac concentration dosed to the patient.Type: ApplicationFiled: November 4, 2016Publication date: February 23, 2017Applicant: BAUSCH & LOMB PHARMA HOLDINGS CORP.Inventors: Angel Padilla, George Baklayan
-
Patent number: 9517220Abstract: Formulations and methods that provided enhanced bromfenac penetration into ocular tissue when topically administered, compared to the currently available BROMDAY™ formulation and method when topically administered. The formulations and methods did so while retaining the patient convenience of a once-daily administration and advantageously lowered the bromfenac concentration dosed to the patient.Type: GrantFiled: October 11, 2012Date of Patent: December 13, 2016Assignee: Bausch & Lomb Pharma Holdings Corp.Inventors: Angel Padilla, George Baklayan
-
Patent number: 8748402Abstract: Provided by the present invention are compositions or formulations suitable for application to a patient's eyes which utilizes a topical ophthalmically-acceptable formulation comprising a therapeutically-effective amount of an ophthalmically-active antimicrobial agent, and an ophthalmically-active anti-inflammatory or steroidal agent in combination with physiologic levels of serum electrolytes in an ophthalmic formulation for the treatment of changes in the normal eye condition. The invention also includes methods of treating patient's having an ophthalmic disease, injury or disorder, utilizing the compositions or formulations. Also provided are kits comprising the compositions or formulations and a means of applying the compositions or formulation to the patient's eyes.Type: GrantFiled: February 9, 2012Date of Patent: June 10, 2014Assignee: Bausch & Lomb Pharma Holdings Corp.Inventors: Mark Abelson, Kirk McMullin, Angel Padilla
-
Publication number: 20130096199Abstract: Formulations and methods that provided enhanced bromfenac penetration into ocular tissue when topically administered, compared to the currently available BROMDAY™ formulation and method when topically administered. The formulations and methods did so while retaining the patient convenience of a once-daily administration and advantageously lowered the bromfenac concentration dosed to the patient.Type: ApplicationFiled: October 11, 2012Publication date: April 18, 2013Inventors: Angel Padilla, George Baklayan
-
Publication number: 20130046240Abstract: Novel compositions including bepotastine besilate are provided such as sorbitol-free compositions, compositions including at least about 0.008% w/v benzalkonium chloride, and compositions including hydroxypropylmethyl cellulose E15 LV.Type: ApplicationFiled: October 6, 2011Publication date: February 21, 2013Inventors: Angel Padilla, George Baklayan
-
Publication number: 20120323178Abstract: Novel compositions including bepotastine besilate and a corticosteroid are provided, compositions including at least about 0.008% w/v benzalkonium chloride, and compositions including hydroxypropylmethyl cellulose E15 LV.Type: ApplicationFiled: January 3, 2012Publication date: December 20, 2012Applicants: Mitsubishi Tanabe Pharma Corporation, ISTA Pharmaceuticals, Inc.Inventors: Angel Padilla, George Baklayan
-
Publication number: 20120255544Abstract: Novel compositions including bepotastine besilate and a corticosteroid are provided, compositions including at least about 0.008% w/v benzalkonium chloride, and compositions including hydroxypropylmethyl cellulose E15 LV.Type: ApplicationFiled: May 2, 2012Publication date: October 11, 2012Applicants: ISTA Pharmaceuticals, Inc.Inventors: Angel Padilla, George Baklayan
-
Publication number: 20120225905Abstract: Novel compositions including bepotastine besilate are provided such as sorbitol-free compositions, compositions including at least about 0.008% w/v benzalkonium chloride, and compositions including hydroxypropylmethyl cellulose E15 LV.Type: ApplicationFiled: May 2, 2012Publication date: September 6, 2012Applicants: Mitsubishi Tanabe Pharma Corporation, ISTA Pharmaceuticals, Inc.Inventors: Angel Padilla, George Baklayan
-
Publication number: 20120195972Abstract: Provided by the present invention are compositions or formulations suitable for application to a patient's eyes which utilizes a topical ophthalmically-acceptable formulation comprising a therapeutically-effective amount of an ophthalmically-active antimicrobial agent, and an ophthalmically-active anti-inflammatory or steroidal agent in combination with physiologic levels of serum electrolytes in an ophthalmic formulation for the treatment of changes in the normal eye condition. The invention also includes methods of treating patient's having an ophthalmic disease, injury or disorder, utilizing the compositions or formulations. Also provided are kits comprising the compositions or formulations and a means of applying the compositions or formulation to the patient's eyes.Type: ApplicationFiled: February 9, 2012Publication date: August 2, 2012Applicant: ISTA Pharmaceuticals, Inc.Inventors: Mark Abelson, Kirk McMullin, Angel Padilla
-
Patent number: 8115649Abstract: An apparatus comprises a sensor system, a flexible line, and a sensor. The sensor system is capable of detecting skew in at least some of a plurality of control surfaces for a vehicle. The flexible line extends across a number of interfaces for a portion of the plurality of control surfaces. The sensor is connected to the flexible line and is capable of detecting the skew in the portion of the plurality of control surfaces in response to a selected amount of movement of the flexible line.Type: GrantFiled: April 30, 2009Date of Patent: February 14, 2012Assignee: The Boeing CompanyInventors: George Moy, Peter Angel Padilla, Michael Edward Renzelmann, Mark J. Gardner, Charles E. Jokisch, William Suhail Hanna, Eric J. Selby, Mark A. Barr, Stephen Roger Amorosi
-
Publication number: 20100277346Abstract: An apparatus comprises a sensor system, a flexible line, and a sensor. The sensor system is capable of detecting skew in at least some of a plurality of control surfaces for a vehicle. The flexible line extends across a number of interfaces for a portion of the plurality of control surfaces. The sensor is connected to the flexible line and is capable of detecting the skew in the portion of the plurality of control surfaces in response to a selected amount of movement of the flexible line.Type: ApplicationFiled: April 30, 2009Publication date: November 4, 2010Applicant: THE BOEING COMPANYInventors: George Moy, Peter Angel Padilla, Michael Edward Renzelmann, Mark J. Gardner, Charles E. Jokisch, William Suhail Hanna, Eric J. Selby, Mark A. Barr, Stephen Roger Amorosi